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A B S T R A C T
Streptococcus agalactiae (S. agalactiae) is a major cause of invasive disease in neonates and pregnant
women, but has also recently been observed among non-pregnant adults, especially elderly persons or
persons with underlying chronic disease. S. agalactiae is also a rare cause of infective endocarditis, and
most cases require early surgery. We report the case of a 43-year-old previously healthy man who
experienced rapid progressive culture-negative infective endocarditis with aortic valve vegetation and
severe aortic regurgitation, which was complicated by lumbar spondylodiscitis. Emergency aortic valve
replacement was performed on the day of his admission, which revealed a congenital bicuspid aortic
valve was ruptured by the vegetation. The resected aortic valve specimen was submitted for 16S
ribosomal RNA gene sequencing, which revealed that the pathogen was S. agalactiae. Therefore,
S. agalactiae should be considered a potentially causative pathogen in cases of rapid progressive infective
endocarditis, even if it occurs in a non-pregnant immunocompetent adult.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Streptococcus agalactiae (S. agalactiae) is also known as group B
streptococcus (GBS), and causes invasive disease in neonates and
pregnant women. However, the incidence of invasive GBS disease
among non-pregnant adults has recently increased, especially
among elderly persons. Nevertheless, invasive GBS disease is rare
among non-pregnant immunocompetent adults, and most
patients have a chronic underlying disease, such as diabetes
mellitus, neurological disease, renal failure, malignancy, or liver
disease [1–4]. S. agalactiae is also a rare cause of infective
endocarditis (IE), and most cases require early surgery because of
serious complications, such as major emboli or heart failure with
rapid heart valve destruction [5–8]. Identiﬁcation of the causative
pathogen is essential for the diagnosis and appropriate treatment
of IE, although blood culture-negative endocarditis accounts for
2.5–31% of all cases of endocarditis [9]. One of the most common
causes of blood culture-negative endocarditis is the administration
of antimicrobial agents before performing the blood cultures. In
this report, we describe our experience with a case of rapid* Corresponding author at: Department of General Medicine, Juntendo University
Faculty of Medicine, 211, Hongo, Bunkyoku, Tokyo, 1138421, Japan.
E-mail address: y-hirai@juntendo.ac.jp (Y. Hirai).
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2214-2509/ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article unprogressive culture-negative IE in an immunocompetent man,
which was caused by S. agalactiae, based on the results from 16S
ribosomal RNA (16S rRNA) gene sequencing using the resected
valve.
Case report
A 43-year-old previously healthy Japanese man presented with
a 3-week history of a high-grade fever ( > 39 C), rigor, and
lumbago. He was treated for a common cold using cefditoren
pivoxil, although his family physician did not perform blood
cultures. The patient was subsequently referred to our hospital
because his symptoms did not resolve. On the ﬁrst day, chest
computed tomography revealed bilateral lower lobe consolidation
with pleural effusion. Therefore, we performed two sets of blood
cultures and started treatment using ceftriaxone (2 g once daily),
based on a preliminary diagnosis of community-acquired pneu-
monia. One week after his ﬁrst visit, he was admitted to our
hospital after he developed dyspnea with or without effort (body
temperature: 36.5 C, heart rate: 117 beats/min, blood pressure:
98/55 mmHg, respiratory rate: 20 breaths/min, and oxygen
saturation: 95% in room air). Chest radiography revealed a butterﬂy
shadow with cardiomegaly and bilateral pleural effusion, which
was consistent with congestive heart failure. Transthoracicder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. A. The resected aortic valve revealed a bicuspid valve (fusion of the right and
left coronary cusps), which was ruptured by the vegetation. B. Gram staining of the
resected specimen reveals Gram-positive cocci (1000).
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valve and severe aortic regurgitation (Fig. 1). A detailed medical
interview revealed that he had undergone dental care without
tooth extraction at 1 month before his presentation to our hospital.
At the admission, we started treatment using ampicillin/
sulbactam (12 g daily in four doses) and gentamicin (180 mg daily
in three doses) instead of ceftriaxone for native valve endocarditis,
and the patient immediately underwent emergency aortic valve
replacement. The resected aortic valve was bicuspid (fusion of the
right and left coronary cusps), and both leaﬂets of the bicuspid
aortic valve (BAV) were ruptured by the vegetation (Fig. 2a). No
organisms were detected from a total of four sets of blood cultures
that were performed before the surgery. Gram staining of the
resected valve revealed Gram-positive cocci (Fig. 2b), although no
organisms were found in the tissue culture. Therefore, we
performed 16S rRNA gene sequencing using the resected valve,
which revealed bacterial DNA that was 99% identical to the
sequence of S. agalactiae. Magnetic resonance imaging on day
8 also revealed spondylodiscitis in the L5 and S1 vertebrae and in
the L5–S1 disc space (Fig. 3). Therefore, we diagnosed the patient
as having IE that was caused by S. agalactiae and complicated by
lumbar spondylodiscitis. On day 29, the antimicrobial treatment
was changed to ampicillin monotherapy (12 g daily in six doses).
On day 43 after the surgery, the intravenous ampicillin was
changed to oral amoxicillin (1500 mg daily in three doses) to treat
the spondylodiscitis. The patient was discharged from our hospital
on day 51, and subsequently completed the 106-day regimen of
antimicrobial treatment.
Discussion
The course of this case highlights two important clinical issues.
First, S. agalactiae should be considered a potentially causative
pathogen in cases of rapid progressive IE, even among non-
pregnant immunocompetent adults. Although GBS is a rare cause
of IE, GBS endocarditis is associated with a poor prognosis (a
mortality rate of 35–56% because of major emboli or heart failure),
compared to IE that is caused by other streptococci (e.g., the
viridans group); therefore, early surgery is recommended for GBS
endocarditis [5–8]. In the present case, the man did not exhibit the
typical risk factors for GBS disease, although we discovered that he
had undiagnosed congenital BAV. Similarly, most cases of BAV are
not detected until the onset of infection or calciﬁcation, despite
BAV being the most common congenital cardiac abnormality
(found in 1–2% of the population) [10].Fig. 1. Transthoracic echocardiography reveals a 12  10-mm vegetation on the
aortic valve (arrow).The second important clinical issue from the present case is that
antimicrobial stewardship should be considered, as the adminis-
tration of antimicrobial agents before performing blood cultures is
a major cause of culture-negative IE. Given that blood culture-
negative IE accounts for 2.5–31% of all IE cases, it remains
challenging to diagnose and appropriately treat. Up to 61% of
culture-negative IE resulted from administration antimicrobial
agents before performing blood cultures [9]. Thus, genetic testing
(e.g., 16S rRNA gene sequencing) can be useful for identifying the
causative pathogen in patients with culture-negative IE. Further-
more, 16S rRNA gene sequencing using the resected heart valve
specimen is an important tool for complementing the diagnosis
and therapeutic management of culture-negative IE [11,12]. One
reported case of culture-negative IE was caused by S. agalactiae
identiﬁed using 16S rRNA gene sequencing, although the patient
died from progressive heart failure despite receiving antimicrobial
treatment without surgery [13]. To the best of our knowledge, the
present case is the ﬁrst successfully treated case of IE that was
caused by S. agalactiae identiﬁed using 16S rRNA gene sequencing
in a non-pregnant immunocompetent adult.
Although GBS has been considered completely susceptible to
penicillin, an increasing number of Japanese isolates exhibit GBS
with reduced penicillin susceptibility (PRGBS). The minimum
inhibitory concentration (MIC) of penicillin G for PRGBS is
0.25–1.0 mg/mL [14,15]. However, the clinical signiﬁcance of
isolated PRGBS remains unclear, and most isolates are from elderly
Fig. 3. Short-tau inversion-recovery (STIR) T2-weighted magnetic resonance
imaging reveals high signal intensity in the L5 and S1 vertebrae and the L5–
S1 disc space (arrow).
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the patient was successfully treated using antimicrobial therapy
(ampicillin/sulbactam and gentamicin) and surgery. Therefore,
although we could not perform antimicrobial susceptibility
testing, we selected ampicillin to replace the ampicillin/sulbactam
as deﬁnitive therapy for the IE, after we had identiﬁed the
S. agalactiae using 16S rRNA gene sequencing.
Conclusion
S. agalactiae can causes rapid progressive IE, even among non-
pregnant immunocompetent adults. Furthermore, antimicrobial
stewardship is important, as the administration of antimicrobial
agents before performing blood cultures is a major cause of
culture-negative IE. Therefore, although S. agalactiae is a rare cause
of rapid progressive IE, it should be considered as a potentially
causative pathogen, even among non-pregnant immunocompe-
tent adults. The increasing incidence of PRGBS with elevatedb-lactam MICs may make it increasingly difﬁcult to select an
appropriate antimicrobial treatment for GBS endocarditis.
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